Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Return on Equity (2022 - 2025)

Historic Return on Equity for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to 2.47%.

  • Gossamer Bio's Return on Equity rose 35700.0% to 2.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.47%, marking a year-over-year increase of 35700.0%. This contributed to the annual value of 1.23% for FY2024, which is 35800.0% up from last year.
  • Gossamer Bio's Return on Equity amounted to 2.47% in Q3 2025, which was up 35700.0% from 5.4% recorded in Q2 2025.
  • Gossamer Bio's 5-year Return on Equity high stood at 27.37% for Q1 2023, and its period low was 9.11% during Q3 2023.
  • Its 4-year average for Return on Equity is 0.77%, with a median of 1.48% in 2024.
  • The largest annual percentage gain for Gossamer Bio's Return on Equity in the last 5 years was 80200bps (2024), contrasted with its biggest fall of -312900bps (2024).
  • Quarter analysis of 4 years shows Gossamer Bio's Return on Equity stood at 6.75% in 2022, then skyrocketed by 68bps to 2.17% in 2023, then soared by 35bps to 1.42% in 2024, then surged by 274bps to 2.47% in 2025.
  • Its Return on Equity stands at 2.47% for Q3 2025, versus 5.4% for Q2 2025 and 4.63% for Q1 2025.